← Leaderboards
Saurabh Chatterjee
Veterans Health Administration
$2,735,380
Attributed
$2,735,380
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500.2K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,735,380 · 3
VA$0 · 2
By mechanism
P01$1,340,343 · 1
R00$746,790 · 1
P20$648,247 · 1
I01$0 · 2
Top collaborators
- Nancy Grace Klimas3 shared
- Ashok K Tuteja3 shared
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryInflammationGut MicrobiomeEventPatternPathologyAffectLinkSymptomsExposure ToAttenuationCytokineProteinsKnockout MiceRodent ModelRodentPattern Recognition ReceptorToxinOxidative StressPathologicInnovationEndotoxemiaLeadAttenuated
Grant awards (21)
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness$0
I01 · FY2025 · VA · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2024 · VA · contact PI
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness$0
I01 · FY2024 · VA · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2023 · VA · contact PI
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness$0
I01 · FY2023 · VA · contact PI
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease$265,565
P01 · FY2022 · ES · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2022 · VA · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2022 · VA · contact PI
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease$265,437
P01 · FY2021 · ES · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2021 · VA · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2021 · VA · contact PI
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease$264,553
P01 · FY2020 · ES · contact PI
Modulation of micro-RNA and inflammation by Andrographolide in NAFLD pathology$212,030
P20 · FY2020 · GM · contact PI
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease$264,387
P01 · FY2019 · ES · contact PI
Modulation of micro-RNA and inflammation by Andrographolide in NAFLD pathology$216,467
P20 · FY2019 · GM · contact PI
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments$0
I01 · FY2019 · VA · contact PI
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease$280,401
P01 · FY2018 · ES · contact PI
Modulation of micro-RNA and inflammation by Andrographolide in NAFLD pathology$219,750
P20 · FY2018 · GM · contact PI
Free Radical Mechanism in Obesity Potentiation of Environmental Hepatotoxicity$248,930
R00 · FY2014 · ES · contact PI
Free Radical Mechanism in Obesity Potentiation of Environmental Hepatotoxicity$248,930
R00 · FY2013 · ES · contact PI
Free Radical Mechanism in Obesity Potentiation of Environmental Hepatotoxicity$248,930
R00 · FY2012 · ES · contact PI